<DOC>
	<DOCNO>NCT02291237</DOCNO>
	<brief_summary>This study evaluate effect eleclazine ( GS-6615 ) exercise capacity , quality life , safety tolerability eleclazine participant symptomatic hypertrophic cardiomyopathy ( HCM ) .</brief_summary>
	<brief_title>Effect Eleclazine ( GS-6615 ) Exercise Capacity Subjects With Symptomatic Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Key Established diagnosis hypertrophic cardiomyopathy define standard criterion maximal leave ventricular wall thickness ≥ 15 mm initial diagnosis Exertional symptom include least one follow : New York Heart Association ( NYHA ) Class ≥ II dyspnea Canadian Cardiovascular Society ( CCS ) Class ≥ II angina Screening ( baseline ) peak VO2 &lt; 80 % predicted age , sex , weight Ability perform upright treadmill cardiopulmonary exercise test ( CPET ) Key Known aortic valve stenosis ( moderate severe ) Known coronary artery disease Left ventricular systolic dysfunction ( ejection fraction &lt; 50 % ) Recent septal reduction procedure ( ie , surgical myectomy alcohol septal ablation ) within six month prior screen procedure schedule occur study Note : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypertrophic cardiomyopathy</keyword>
	<keyword>hcm</keyword>
	<keyword>hocm</keyword>
	<keyword>hypertrophic myocardiopathy</keyword>
	<keyword>hypertrophic obstructive cardiomyopathy</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>hypertrophic</keyword>
	<keyword>familial hypertrophic cardiomyopathy</keyword>
	<keyword>genetic heart disease</keyword>
	<keyword>echocardiography</keyword>
	<keyword>cardiopulmonary exercise testing</keyword>
	<keyword>exercise Capacity</keyword>
	<keyword>heart failure</keyword>
	<keyword>angina</keyword>
	<keyword>dyspnea</keyword>
	<keyword>diastolic dysfunction</keyword>
	<keyword>microvascular ischemia</keyword>
	<keyword>late sodium current inhibitor</keyword>
	<keyword>GS-6615</keyword>
	<keyword>late INA</keyword>
</DOC>